Icosavax, Inc. License Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 3 to Exclusive Patent License Agreement, dated May 24, 2023, between the Registrant and National Institute of Allergy and Infectious Diseases
License Agreements
Icosavax, Inc.
Biotechnology
2023
Amended and Restated Exclusive License Agreement, dated June 8, 2023, between the Registrant and the University of Washington
License Agreements
Icosavax, Inc.
Biotechnology
WA
2023
Amendment No. 3 to Exclusive License Agreement, effective as of June 3, 2022, between University of Washington and the Registrant
License Agreements
Icosavax, Inc.
Biotechnology
2022
Non-Exclusive License Agreement, dated September 16, 2021, by and between the University of Washington and the Registrant
License Agreements
Icosavax, Inc.
Biotechnology
WA
2022
Patent License Agreement, dated June 2, 2021, between the Registrant and the University of Texas at Austin
License Agreements
Icosavax, Inc.
Biotechnology
TX
2021
Non-Exclusive Patent License Agreement, dated June 28, 2018, between the Registrant and National Institute of Allergy and Infectious Diseases, as amended
License Agreements
Icosavax, Inc.
Biotechnology
2021
License and Exclusive Option Agreement, dated July 2, 2020, between the Registrant and University of Washington, as amended
License Agreements
Icosavax, Inc.
Biotechnology
WA
2021
Exclusive License Agreement, dated June 29, 2018, between the Registrant and University of Washington, as amended
License Agreements
Icosavax, Inc.
Biotechnology
WA
2021